{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:34:46Z","timestamp":1781811286255,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","so-online.net","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.suronc.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T06:49:06Z","timestamp":1434264546000},"page":"270-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Is radioembolization (90Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Olaguoke","family":"Akinwande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-8643","authenticated-orcid":false,"given":"Jacob","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prejesh","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Scoggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert C.G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.suronc.2015.06.008_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J.\u00a0Hepatol."},{"issue":"8","key":"10.1016\/j.suronc.2015.06.008_bib3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jvir.2009.10.013","article-title":"Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"21","author":"Kooby","year":"2010","journal-title":"J.\u00a0Vasc. Interv. Radiol. JVIR"},{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suronc.2015.06.008_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000348325","article-title":"Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90","volume":"84","author":"Lau","year":"2013","journal-title":"Oncology"},{"issue":"47","key":"10.1016\/j.suronc.2015.06.008_bib8","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.3748\/wjg.v12.i47.7561","article-title":"Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus","volume":"12","author":"Minagawa","year":"2006","journal-title":"World J. Gastroenterol WJG"},{"issue":"1","key":"10.1016\/j.suronc.2015.06.008_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suronc.2015.06.008_bib10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.20.6.1527","article-title":"Simplified staging for hepatocellular carcinoma","volume":"20","author":"Vauthey","year":"2002","journal-title":"J.\u00a0Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatol. Int."},{"issue":"Suppl.\u00a05","key":"10.1016\/j.suronc.2015.06.008_bib12","doi-asserted-by":"crossref","first-page":"v59","DOI":"10.1093\/annonc\/mdq166","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Jelic","year":"2010","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncology\/ESMO"},{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study","volume":"18","author":"Luo","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2015.06.008_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1148\/radiol.10101058","article-title":"Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival","volume":"258","author":"Chung","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.suronc.2015.06.008_bib15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2015.06.008_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suronc.2015.06.008_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J.\u00a0Hepatol."},{"issue":"1","key":"10.1016\/j.suronc.2015.06.008_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc. Interv. Radiol."},{"issue":"6","key":"10.1016\/j.suronc.2015.06.008_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","article-title":"Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)","volume":"101","author":"Dhanasekaran","year":"2010","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2015.06.008_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jamcollsurg.2008.12.009","article-title":"Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?","volume":"208","author":"Woodall","year":"2009","journal-title":"J.\u00a0Am. Coll. Surg."},{"issue":"13","key":"10.1016\/j.suronc.2015.06.008_bib21","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J.\u00a0Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2015.06.008_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.suronc.2015.06.008_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2407-12-263","article-title":"The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma","volume":"12","author":"Qu","year":"2012","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2015.06.008_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.suronc.2015.06.008_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.suronc.2015.06.008_bib26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.suronc.2015.06.008_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jvir.2010.04.012","article-title":"Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis","volume":"21","author":"Inarrairaegui","year":"2010","journal-title":"J.\u00a0Vasc. Interv. Radiol. JVIR"},{"issue":"9","key":"10.1016\/j.suronc.2015.06.008_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jvir.2010.04.027","article-title":"Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis","volume":"21","author":"Tsai","year":"2010","journal-title":"J.\u00a0Vasc. Interv. Radiol. JVIR"},{"issue":"2 Pt 1","key":"10.1016\/j.suronc.2015.06.008_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","article-title":"DC bead: in\u00a0vitro characterization of a drug-delivery device for transarterial chemoembolization","volume":"17","author":"Lewis","year":"2006","journal-title":"J.\u00a0Vasc. Interv. Radiol. JVIR"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740415300086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740415300086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:42:43Z","timestamp":1599133363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740415300086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0960740415300086"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2015.06.008","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is radioembolization (90Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}